8-K - EXELIXIS, INC. (0000939767) (Filer)
Published . Updated .
8-K - EXELIXIS filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- EXEL Exelixis+23.4% 13d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Exelixis belongs to, so it often moves with news about it.
- AMGN Amgen+18.4% 30d
Amgen is a peer of Exelixis in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+16.6% 30d
Gilead Sciences is a peer of Exelixis in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+28.2% 30d
Moderna is a peer of Exelixis in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.4% 17d
argenx SE is a peer of Exelixis in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Exelixis in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| EXEL | -2.63% | -1.39% | base | +4.71% | +5.85% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0000939767-26-000114 Size: 462 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Exelixis (EXEL)
| Company | When | Move | Status |
|---|---|---|---|
| Exelixis (EXEL) | that day | +4.71% | final price |
| Exelixis (EXEL) | the next day | +5.85% | still updating |
| Exelixis (EXEL) | three days earlier | -1.39% | final price |
| Exelixis (EXEL) | five days earlier | -2.63% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 37 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 78 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 80 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 62 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - EXELIXIS, INC. (0000939767) (Filer)”
Companies tied to this story
- EXEL Exelixis
For “8-K - EXELIXIS, INC. (0000939767) (Filer),” Exelixis (EXEL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> EXEL
How “8-K - EXELIXIS, INC. (0000939767) (Filer)” reaches Exelixis (EXEL)
Exelixis (EXEL) is the company in “8-K - EXELIXIS, INC. (0000939767) (Filer),” the 29 Oct 2026 this story story.
Exelixis (EXEL) is on the page because SEC 8-K filing -> direct issuer disclosure -> EXEL
Dates in the story, and the Exelixis (EXEL) price range
EXEL traded between 54.95 and 72.07 across 12 sessions. The latest close on file is 69.38.
What the saved facts support for Exelixis (EXEL)
14 out of 100Price not final
“8-K - EXELIXIS, INC. (0000939767) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.